Author

Jen Yesil

Institution: Multiple Myeloma Research Foundation

Observed institutions: Translational Genomics Research Institute, Multiple Myeloma Research Foundation

OpenAlex ID: A5032536741

Myeloma developing regimens using genomics (MyDRUG) trial: Results from the RAS mutation targeting arm.

2022 · Shaji Kumar, Giada Bianchi, et al. · Journal of Clinical Oncology · 10

High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments

2022 · Nicolas Fernandez, Deepak Perumal, et al. · Clinical Lymphoma Myeloma & Leukemia · 5

Abstract 3006: Molecular characterization of baseline and serial multiple myeloma patients from the MMRF CoMMpass study

2018 · Sheri Skerget, Austin Christofferson, et al. · Cancer Research

Works count: 3

Citation count: 15

H-index: 2

I10-index: 1